In this webinar, Dr. James E. Crowe from Vanderbilt University Medical Center will discuss current approaches to screening for high potency, broad reactivity, synergistic combinations and reduced escapability.

In this webinar, our expert speaker will discuss the types of analytical testing that can be effectively employed in the early stages of therapeutic development and subsequently scaled to meet production challenges.

Advances in monoclonal antibody (mAb) engineering have led to additional challenges in the purification of these modalities, including high levels of aggregates. Ion exchange chromatography is often not sufficient to achieve purity targets meaning hydrophobic interaction chromatography (HIC) and mixed-mode resins are needed as orthogonal tools. These technologies can be implemented in flow-through mode allowing for high loadings and fast processing times, making them well-suited for large-scale implementation.

This webinar highlights three case studies that illustrate how novel chromatographic tools can improve the purification process for complex therapeutics by reducing the levels of aggregates and host cell proteins (HCPs) and effectively clearing retroviruses.

The CLIA proficiency testing revisions will take effect on July 11, 2024, introducing significant changes to both microbiology and non-microbiology laboratory sections. These updates include modifications to grading, reporting and the regulation of certain analytes.
Join Dr. Bremansu Osa-Andrews from the University of Florida for an in-depth webinar where he will elucidate the details of the CLIA 2024 final rule, helping laboratories stay informed and prepared for future inspections.

Key advances will be highlighted across the field of immuno-oncology. Hear a cross-section of experts discuss their research with a focus on basic research and a broad range of established and novel immunotherapeutics.

In this webinar, our expert speaker Dr. Stefano Menegatti from NC State University, will discuss his team’s approach in leveraging affinity technology to introduce new tools for purifying and characterizing biotherapeutics to match the growing demands of clinics and biotech industries worldwide.